Fingerprint
Dive into the research topics of 'The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice
Anuj K. Sharma, Rachel L. Roberts, Reginald D. Benson, Jessica L. Pierce, Kanglun Yu, Mark W. Hamrick, Meghan E. McGee-Lawrence
Research output: Contribution to journal › Article › peer-review
59
Scopus
citations